The findings provide contemporary surgical benchmarks, which will become even more important as M-TEER trial data emerge.

Background Recurrent mitral regurgitation (MR) remains a major limitation of mitral valve (MV) repair in patients with ...

Ischemic mitral regurgitation of moderate severity develops in approximately 10% of patients after myocardial infarction. 1,2 Mitral regurgitation is caused by the displacement of papillary muscle, ...

Mitral valve prolapse treatment aims to relieve symptoms, prevent complications, and improve the quality of life of people who have blood that leaks back into their heart’s left atrium. Mitral valve ...

SAN FRANCISCO — In two forms of severe mitral valve disease with high rates of mortality and limited treatment options, multicenter trials with novel transcatheter devices produced what experts ...

The mitral valve allows blood to flow from the left atrium of the heart into the left ventricle. Mitral regurgitation occurs when the mitral valve leaks blood back into the left atrium. A person’s ...

Mitral valve regurgitation is a common heart valve condition in which the mitral valve cannot close properly. Cardiologists may implant mitral valve clips to help the valve close effectively. Mitral ...

Peer-reviewed independent bench testing examines the TransForm™ mitral valve repair ring and highlights lifetime ...

Doctors classify mitral valve regurgitation into four progressive stages. Symptoms typically don’t appear until the final stages but monitoring and treatment in earlier stages may help slow ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) today announced the company’s SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...